Testing effectiveness (Phase 2)Study completedNCT02712112
What this trial is testing
Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Who this might be right for
Gastrointestinal Stromal Tumors (GISTs)
Asan Medical Center 51